Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 24
Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 2 Attachment B NIH Blue Ribbon Panel to Advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories at Boston University Medical Center September 22, 2010 Hyatt Regency Bethesda 7400 Wisconsin Avenue Bethesda, Maryland 20814 AGENDA 8:45 AM Welcome and Purpose of Today’s Meeting Adel Mahmoud, M.D., Ph.D. Chair, NIH Blue Ribbon Panel Professor, Department of Molecular Biology, Princeton University 8:55 AM Opening Remarks John F. Ahearne, Ph.D., Committee Chair, National Research Council 9:00 AM Roundtable Introduction of Blue Ribbon Panel and National Research Council Members 9:10 AM Introduction and Overview of Today’s Presentations Frank Gallegos, Risk Assessment Project Manager, Tetra Tech 9:20 AM Release Event Selection and Analysis Ken Bulmahn, Tetra Tech Risk Assessment Team Lead 10:00 AM Discussion 10:30 AM Break 10:45 AM Probability of Initial Infections Adi Gundlapalli, M.D., Ph.D., M.S., Assistant Professor, Departments of Internal Medicine, Pathology and Biomedical Informatics, University of Utah School of Medicine 11:25 AM Discussion 11:45 PM Break 12:00 PM Modeling Secondary Transmission Damon Toth, Ph.D., Research Assistant Professor, Department of Mathematics, University of Utah
OCR for page 25
Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 2 12:40 PM Discussion 1:10PM Approach to Risk Characterization Adi Gundlapalli, M.D., Ph.D., M.S. 1:30 PM General Discussion 2:30 PM Public Comment 2:50 PM Wrap Up 3:00 PM Adjourn